Skip to main navigation Skip to search Skip to main content

常山酮抗肿瘤作用机制研究进展

Translated title of the contribution: Research progress on anticancer mechanisms of halofuginone
  • 车玉梅
  • , 何小鹃
  • , 徐洁
  • , 马超英
  • , 吕爱平

Research output: Contribution to journalJournal articlepeer-review

1 Citation (Scopus)

Abstract

常山酮(HF)是中药有效成分常山堿的衍生物,长期作为广谱抗球虫药使用。近年来,研究发现HF可促进伤口修复、抑制组织纤维化,其在抗肿瘤临床前研究中表现尤为突出,展示了HF抗肿瘤的巨大潜力。查阅近年来国内外相关文献,从抑制肿瘤细胞增殖、诱导肿瘤细胞凋亡、抗血管新生、抑制纤维母细胞活化和抗炎等方面,综述了HF抗肿瘤研究进展,同时为HF的深入研究提供参考。
Translated title of the contributionResearch progress on anticancer mechanisms of halofuginone
Original languageChinese (Simplified)
Pages (from-to)745-748
Number of pages4
Journal中草药
Volume45
Issue number5
DOIs
Publication statusPublished - 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

User-Defined Keywords

  • Angiogenesis
  • Cell apoptosis
  • Halofuginone
  • Inflammation
  • Th17 cells
  • Tumor

Fingerprint

Dive into the research topics of 'Research progress on anticancer mechanisms of halofuginone'. Together they form a unique fingerprint.

Cite this